Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.7675
-0.0175 (-2.23%)
Apr 4, 2025, 4:00 PM EDT - Market closed
Caribou Biosciences Stock Forecast
CRBU's stock price has decreased by -83.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 11.8, with a low estimate of 6.00 and a high estimate of 19. The average target predicts an increase of 1,437.46% from the current stock price of 0.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caribou Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,072.64% | Mar 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +1,333.22% | Jan 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $6 | Strong Buy | Maintains | $30 → $6 | +681.76% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,072.64% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,072.64% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
9.84M
from 9.99M
Decreased by -1.53%
Revenue Next Year
25.92M
from 9.84M
Increased by 163.34%
EPS This Year
-1.69
from -1.65
EPS Next Year
-1.75
from -1.69
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.7M | 105.0M | 105.0M | ||
| Avg | 9.8M | 25.9M | 44.5M | ||
| Low | n/a | 9.7M | 9.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1% | 967.0% | 305.2% | ||
| Avg | -1.5% | 163.3% | 71.6% | ||
| Low | - | -1.0% | -62.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.86 | -0.53 | 2.55 | ||
| Avg | -1.69 | -1.75 | -1.41 | ||
| Low | -2.28 | -2.73 | -3.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.